Abacus was launched in 2014 by Aidance Scientific. Aidance, formed in 2004, is a cGMP manufacturer of a unique, broad-spectrum antimicrobial technology for dermatological products. Aidance distributes its products to major national retail chains, as well as direct to consumers globally through its retail web platforms.
Abacus is the first company to develop a a family of OTC products blended with CBD hemp extract (Cannabis sativa L.) and began distribution to healthcare practitioners in 2016 under the CBD CLINIC brand name. CBD CLINIC products quickly became the #1 preferred external analgesics for thousands of practitioners across the United States. In the third quarter of 2018, Abacus launched the CBDMEDIC brand directly to the consumer and mass retail markets. Abacus expanded its product line in 2019 to include a full range of pain relief products as well as a new skincare line.
Abacus became a publicly traded company after completing an RTO on the Canadian Securities Exchange on January 30, 2019 and acquired by Charlotte’s Web Holdings, Inc. on June 11, 2020.